Johnson & Johnson helps pharmaceutical investigators find coagulant risks

Johnson & Johnson helps pharmaceutical investigators find coagulant risks

by

New York. The Johnson & Johnson company privately filed a lawsuit against pharmacists who also developed a vaccine against COVID-19 while working to study the risks of blood clots and to talk to someone about the safety of the drug, informs Die Wall Street Journal.

According to the periodical, Johnson & Johnson contact AstraZeneca, Pfizer and Modern to a desperate despot of the preoccupations that occur over the development of thrombi in some persons that habían received a dose of the vaccine, pero Moderna y Pfizer rechazaron la oferta.

  2. CDC is not a definite hacer con la vacuna de Johnson & Johnson

  3. Salud’s quedará cojo with 10,000 holidays of COVID-19 due to paralysis and el uso de Johnson & Johnson

  4. Australia reports dead death at AstraZeneca window

In agreement with “familiar sources with the question”, Johnson & Johnson also sought to create an informal alliance to inform about the benefits and risks of receiving the vacancy.

On March, the Centers for the Prevention and Control of Injuries (CDC, in English) under the Administration of Drugs and Food (FDA, in English) sought to authorize the vacancies, recommended suspending the administration of the Johnson & Johnson drug detector six Cases in women less than 48 years of a rare type of cerebral thrombosis, which has a failure and is still serious.

Without embarrassment, the health authorities of the United States insist on the safety of the vacancies, following its recommendation.

However, in the case of Johnson & Johnson, similar cases were discovered in AstraZeneca’s vacant persons, which were not administered in the United States.

Without embarrassment, no cases of this type have been reported in person having been inoculated with Pfizer’s or Modern’s vehicle.

According to The Wall Street Journal, Pfizer & Moderna executives declare the offer to ensure that their formulas are secure and that their names are covered by the Johnson & Johnson association.

In addition, according to the sources, we would consider that additional collaboration duplicates the efforts that regulators and companies are making to investigate possible secondary effects.

Solo AstraZeneca, which has also caused some tornado cases, has shown favor in favor of the association proposed by Johnson & Johnson, according to the media.

.Source